Surface annexin II on placental membranes of the fetomaternal interface

American Journal of Reproductive Immunology

Volumn 36, Issue 3, 1996, Pages 141-149

  Kristoffersen, Einar K ^a,b   Matre, Roald ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Annexin II; Confocal laser scanning microscopy; Fc receptors; Flow cytometry; Syncytiotrophoblast microvillous plasma membrane

Indexed keywords

ALKALINE PHOSPHATASE; CD59 ANTIGEN; IMMUNOGLOBULIN G; LIPOCORTIN 2; MEMBRANE COFACTOR PROTEIN;

ARTICLE; BLOOD PLACENTA BARRIER; CONFOCAL LASER MICROSCOPY; FEMALE; FETUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MATERNAL BLOOD; MICROVILLUS; NORMAL HUMAN; PLACENTA; PLACENTAL TRANSFER; PRIORITY JOURNAL; SYNCYTIOTROPHOBLAST;

EID: 0029813535     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1996.tb00155.x     Document Type: Article

References (58)

1. Holmes CH, Simpson KL, Okada H, et al. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur J Immunol 1992; 22:1579-1585.
2. Rubenstein A, Koren Z, Murphy RA. Suppression of maternal lymphocyte mitogenic response by supernatants from short term placental cell cultures. Am J Reprod Immunol 1982; 2:260-264.
3. Saji F, Koyama M, Kameda T, Negoro T, Nakamuro K, Tanizawa O. Effect of a soluble factor secreted from cultured human trophoblast cells on in vitro lymphocyte reactions [published erratum appears in Am J Reprod Immunol Microbiol 1987 Aug; 14(4): 153]. Am J Reprod Immunol Microbiol 1987; 13(4):121-124.
4. Nicholas NS, Panayi GS. Inhibition of interleukin-2 production by retroplacental sera: a possible mechanism for human fetal allograft survival. Am J Reprod Immunol Microbiol 1985; 9(1):6-11.
5. Sunderland CA, Naiem M, Mason DY, Redman CWG, Stirrat GM. The expression of major histocompatibility antigens by human chorionic villi. J Reprod Immunol 1981; 3:323-331.
6. Yelavarthi KK, Fishback JL, Hunt JS. Analysis of HLA-G mRNA in human placental and extraplacental membrane cells by in situ hybridization. J Immunol 1991; 146(8):2847-2854.
7. Brambell FWR, Halliday R, Brierley J, Hemmings WA. Transference of passive immunity from mother to young. Lancet 1954; 1:964-965.
8. Saji F, Koyama M, Matsuzaki N. Current topic: human placental Fc receptors. Placenta 1994; 15(5):453-466.
9. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 1986; 118:1567-1582.
10. Smith NC, Brush MG, Luckett S. Preparation of human placental villous surface membrane. Nature 1974; 252:302-303.
11. Johnson PM, Brown PJ, Ogbimi AO, Shah LCP. The human syncytiotrophoblast microvillous plasma membrane. New York: Alan R. Liss, Inc., 1981:77-91.
12. Matre R, Haaheim LR, Tønder O. A monoclonal antibody inhibiting human placental Fc gamma-receptor activity. Int Arch Allergy Appl Immunol 1984;75:227-229.
13. Kristoffersen EK, Ulvestad E, Bjørge L, Aarli Å, Matre R. Fc gamma receptor activity of human placental annexin II. Scand J Immunol 1994; 40:237-242.
14. Di Rosa M, Flower RJ, Hirata F, Parente L, Russo Marie F. Anti-phospholipase proteins. Prostaglandins 1984; 28(4):441-442.
15. Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1994; 197:63-93.
16. Tressler RJ, Updyke TV, Yeatman T, Nicolson GL. Extracellular annexin II is associated with divalent cation-dependent tumor cell-endothelial cell adhesion of metastatic RAW117 large-cell lymphoma cells. J Cell Biochem 1993; 53:265-276.
17. Ma ASP, Bell DJ, Mittal AA, Harrison HH. Immunocytochemical detection of extracellular annexin II in cultured human skin keratinocytes and isolation of annexin II isoforms enriched in the extracellular pool. J Cell Sci 1994; 107:1973-1984.
18. Yeatman TJ, Updyke TV, Kaetzel MA, Dedman JR, Nicolson GL. Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cells. Clin Exp Metastasis 1993; 11:37-44.
19. Rand JH, Wu XX, Guller S, et al. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol 1994; 171(6):1566-1572.
20. Lee T, Lin Y, Mochitate F, Grinelle F. Stress-relaxation of fibroblasts in collagen matrices triggers ectocytosis of plasma membrane vesicles containing actin, annexins II and VI, and beta-1 integrin receptors. J Cell Sci 1993; 105(1):167-177.
21. Sakata T, Iwagami S, Tsuruta Y, et al. The role of lipocortin I in macrophage-mediated immunosuppression in tumor-bearing mice. J Immunol 1990; 145:387-396.
22. Ulvestad E, Kristoffersen EK, Skeie Jensen T, Matre R. Identification of a soluble human Fc gamma receptor (annexin II) using a competitive ELISA. APMIS 1994; 102:667-673.
23. Kumble KD, Vishwanatha JK. Immunoelectron microscopic analysis of the intracellular distribution of primer recognition proteins, annexin 2 and phosphoglycerate kinase, in normal and transformed cells. J Cell Sci 1991; 99(Pt 4):751-758.
24. Harder T, Gerke V. The subcellular distribution of early endosomes is affected by the annexin II2p11(2) complex. J Cell Biol 1993; 123:1119-1132.
25. Gould KL, Woodgett JR, Isacke CM, Hunter T. The protein-tyrosine kinase substrate p36 is also a substrate for protein kinase C in vitro and in vivo. Mol Cell Biol 1986; 6(7):2738-2744.
26. Huang KS, Wallner BP, Mattaliano RJ, et al. Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60v-src and of the epidermal growth factor receptor/ kinase. Cell 1986; 46:191-199.
27. Wright JF, Kurosky A, Wasi S. An endothelial cell-surface form of annexin II binds human cytomegalovirus. Biochem Biophys Res Commun 1994; 198(3):983-989.
28. Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA) .2. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem 1994; 269:21198-21203.
29. Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 1994; 269:21191-21197.
30. Chung CY, Erickson HP. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J Cell Biol 1994; 126:539-548.
31. Webb PD, Mahadevan LC. Calcium-dependant binding proteins associated with human placental syncytiotrophoblast microvillous cytoskeleton. Biochim Biophys Acta 1987; 916:288-297.
32. Goulding NJ, Guyre PM. Impairment of erythrocyte-antibody rosette formation by human lipocortin 1 on human leucocytes. Biochem Soc Trans 1988; 16:730-731.
33. Matre R, Kristoffersen EK, Ulvestad E, Vedeler CA. Purification of a functional 40 kD human placental Fc gamma receptor using a monoclonal antibody. APMIS 1989; 97:733-737.
34. Mellman I, Fuchs R, Helenius A. Acidification of the endocytic and exocytic pathways. Ann Rev Biochem 1986; 55:663-700.
35. Simister NE, Chen H-L, Story CM, Hunt JS. Localization of the neonatal Fc receptor in human placenta. IX International Immunology Conference. San Francisco, 1995.
36. Story CM, Mikulska JE, Simister NE. A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus. J Exp Med 1994; 180(6):2377-2381.
37. Balfour AH, Jones EA. The binding of plasma proteins to human placental cell membranes. Clin Sci Mol Med 1977; 52:383-394.
38. Brown PJ, Johnson PM. Fc gamma-receptor activity of isolated human placental syncytiotrophoblast plasma membrane. Immunolology 1981; 42(2):313-319.
39. Watabe H, Gitlin JI, Gitlin D. Further characterization of IgG receptors from human placenta. J Biochem 1980; 87:393-397.
40. O'Sullivan MJ, McIntyre JA, Warriner G, Faulk WP. Biochemical studies of human syncytiotrophoblastic plasma membrane proteins. J Reprod Immunol 1981; 3:297-306.
41. Ogbimi AO, Johnson PM, Brown PJ, Fox H. Characterisation of the soluble fraction of human syncytiotrophoblast microvillous plasma membrane-associated proteins. J Reprod Immunol 1979; 1:127-140.
42. McNabb T, Koh TY, Dorrington KJ, Painter RH. Structure and function of immunoglobulin domains: V. Binding of immunoglobulin G and fragments to placental membrane preparations. J Immunol 1976; 117(3):882-888.
43. Thaler CJ, McIntyre JA, Faulk WP. Fc receptor and trophoblast antigens in seminal plasma: a potential stimulus to prime mothers for implantation. Immunol Lett 1990; 26(2):145-151.
44. Nishikiori N, Koyama M, Kikuchi T, et al. Membrane-spanning Fc gamma receptor III isoform expressed on human placental trophoblasts. Am J Reprod Immunol 1993; 29:17-25.
45. Huizinga TW, Kuijpers RW, Kleijer M, et al. Maternal genomic neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia [see comments]. Blood 1990; 76:1927-1932.
46. Friden BE, Makiya R, Nilsson BM, Holm S, Stigbrand TI. The human placental immunoglobulin G receptor and immunoglobulin G transport. Am J Obstet Gynecol 1994; 171:258-263.
47. Makiya R, Stigbrand T. Placental alkaline phosphatase as the placental IgG receptor. Clin Chem 1992; 38(12):2543-2545.
48. Jones CJP, Fox H. An ultrahistochemical study of the distribution of acid and alkaline phosphatases in placentae from normal and complicated pregnancies. J Pathol 1976; 118:143-151.
49. Goldstein DJ, Harris H. Human placental alkaline phosphatase differs from that of other species. Nature 1979; 280:602-604.
50. Brambell FWR. The transmission of passive immunity from mother to young. In Neuberger A, Tatum EL (eds): Frontiers of Biology (vol 18). Amsterdam: North-Holland Publishing Company, 1970.
51. Tait JF, Sakata M, McMullen BA, et al. Placental anticoagulant proteins: Isolation and comparative characterization of four members of the lipocortin family. Biochemistry 1988; 27:6268-6276.
52. Cirino G, Peers SH, Flower RJ, Browning JL, Pepinsky RB. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. Proc Natl Acad Sci USA. 1989; 86:3428-3432.
53. Goulding NJ, Guyre PM. Glucocorticoids, lipocortins and the immune response. Curr Opin Immunol 1993; 5: 108-113.
54. Degenne D, Khalfoun B, Bardos P. In vitro inhibitory effect of human syncytiotrophoblast plasma membranes on the cytolytic activities of CTL and NK cells. Am J Reprod Immunol Microbiol 1986; 12(4):106-110.
55. Kristoffersen EK, Matre R. Local immunosuppression of syncytiotrophoblast microvilli in pregnancy. IX International Immunology Conference. San Francisco, 1995.
56. Yan JH, Zhu XH. Immunoregulatory functions of syncytiotrophoblast microvillous plasma membrane (StMPM). IX International Immunology Conference, San Francisco, 1995.
57. Arkwright PD, Redmann CWG. Syncytiotrophoblast membrane glycoprotein components block lymphocyte proliferation by interfering with an early event in their activation. In: Chaouat G, Mowbray J, eds. Cellular and molecular biology of the materno-fetal relationship. (vol 212) John Libbey Eurotext Ltd, 1991:227-235.
58. Aarli A, Skeie Jensen T, Ulvestad E, Matre R. Suppression of mitogen-induced lymphoproliferation by soluble IgG Fc receptors in retroplacental serum in normal human pregnancy. Scand J Immunol 1993; 37:237-243.